Events | Sutro Biopharma, Inc.

Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Events, News, Presentations, Press Releases

Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference SOUTH SAN FRANCISCO, Calif., Oct. 16, 2019 – Sutro Biopharma, Inc. (NASDAQ:...

World Anti-Body Drug Conjugate (ADC) 2019 – Process Development and Scale Up for Site-Specific Bioconjugate Conjugation and Purification Poster

Events, News, Presentations, Press Releases

World Anti-Body Drug Conjugate (ADC) 2019 – Process Development and Scale Up for Site-Specific Bioconjugate Conjugation and Purification Poster Please Click the Link, World ADC 2019 Poster to...

Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference SOUTH SAN FRANCISCO, Calif., Sept. 4, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, CEO of Sutro Biopharma, will present a corporate overview at the...

Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference SOUTH SAN FRANCISCO, Calif., Aug. 8, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise...

Sutro Biopharma to Present at the JMP Securities Life Sciences Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the JMP Securities Life Sciences Conference SOUTH SAN FRANCISCO, Calif., June 18, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise...

Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress

Events, News, Presentations, Press Releases

Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress SOUTH SAN FRANCISCO, Calif., May 16, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that the company will present at the upcoming European Hematology Association...

« Older Entries

Next Entries »